MIDAS
Migraine Disability Assessment
About This Instrument
The Migraine Disability Assessment (MIDAS) questionnaire is a 5-item self-report instrument developed by Walter Stewart and Richard Lipton to quantify headache-related disability over the preceding three months. It counts the number of days with reduced activity across three domains: work or school, household work, and social or leisure activities. Total scores represent lost days, with Grade I (0–5 days) indicating minimal disability through Grade IV (21+ days) indicating severe disability. Two supplementary questions capture headache frequency and average pain intensity. The MIDAS is used in psychedelic headache research alongside the HIT-6 to measure functional impact of cluster headache and migraine. It is simple, validated across multiple cultures, and recommended by the International Headache Society for clinical trials and epidemiological studies.
Clinical Thresholds
Outcome Data Across Studies
Reported results for MIDAS across 1 study with quantitative data.
| SD | ||||||
|---|---|---|---|---|---|---|
| Ketamine for Refractory Chronic Migraine: an Observational Pilot Study and Metabolite Analysis 2021Secondary | Ketamine infusion(experimental) | 0 | 6 | 4.0 | — | — |
Papers Using MIDAS
Quick Facts
- Full Name
- Migraine Disability Assessment
- Domain
- Other
- Papers Indexed
- 1
- Score Range
- 0–270
- Interpretation
- Lower = better
- Unit
- days